-
-
BILL SPONSOR
-
Gus Bilirakis
Republican - FL
-
-
TRACK BILL
-
-
-
-
Sponsor Party
Republican
-
-
-
-
Congress
113
-
-
-
-
Bill Number
H.R.5750
-
-
-
-
Date Introduced
11/20/2014
-
-
-
Bill Progress
BILL INTRODUCED 11/20/2014
SENATE PASSED
HOUSE PASSED
PRESIDENT TO PRESIDENT
PRESIDENT SIGNS
-
-
-
H.R.5750 : To amend the Federal Food, Drug, and Cosmetic Act to authorize a 6-month extension of certain exclusivity periods in the case of approved drugs that are subsequently approved for a new indication to prevent, diagnose, or treat a rare disease or condition, and for other purposes.
-
- Rate Bill
Not yet rated
-
BILL STATUS UPDATE - HR5750-113
12/9/2014
HR5750-113-To amend the Federal Food, Drug, and Cosmetic Act to authorize a 6-month extension of certain exclusivity periods in the case of approved drugs that are subsequently approved for a new indication to prevent, diagnose, or treat a rare disease or condition, and for other purposes.
CURRENT STATUS
Sponsor introductory remarks on measure. (CR H8938)
BILL STATUS UPDATE - HR5750-113
11/19/2014
HR5750-113-To amend the Federal Food, Drug, and Cosmetic Act to authorize a 6-month extension of certain exclusivity periods in the case of approved drugs that are subsequently approved for a new indication to prevent, diagnose, or treat a rare disease or condition, and for other purposes.
CURRENT STATUS
Referred to the House Committee on Energy and Commerce.
-
-
0 Yays 0 Nays
-
-
0 Yays 0 Nays